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ABSTRACT  Two large wastewater treatment plants (WWTP), covering around 2.7 M 21 
inhabitants, which represents around 85% of the metropolitan area of Barcelona, were 22 
sampled before, during and after the implementation of a complete lockdown. Five one-23 
step RT-qPCR assays, targeting the polymerase (IP2 and IP4), the envelope E and the 24 
nucleoprotein (N1 and N2) genome regions, were employed for SARS-CoV-2 RNA 25 
detection in 24-h composite wastewater samples concentrated by polyethylene glycol 26 
(PEG) precipitation.  27 
 SARS-CoV-2 was detected in a sewage sample collected 41 days ahead of the 28 
declaration of the first COVID-19 case. The evolution of SARS-CoV-2 genome copies 29 
in wastewater evidenced the validity of water-based epidemiology to anticipate COVID-30 
19 outbreaks, to evaluate the impact of control measures and even to estimate the 31 
burden of shedders, including presymptomatic, asymptomatic, symptomatic and 32 
undiagnosed cases. For this latter objective, a model was applied for the estimation of 33 
the total number of shedders, evidencing a high proportion of asymptomatic infected 34 
individuals. In this way, an infection prevalence of 2.0-6.5% was figured. On the other 35 
hand, a proportion of around 0.12% and 0.09% of the total population was determined 36 
to be required for positive detection in the two WWTPs. 37 
 At the end of the lockdown, SARS-CoV-2 RNA apparently disappeared in the 38 
WWTPs but could still be detected in grab samples from four urban sewers. Sewer 39 
monitoring allowed for location of specific hot spots of COVID-19, enabling the rapid 40 
adoption of appropriate mitigation measures. 41 
IMPORTANCE  Water-based epidemiology (WBE) is a valuable early warning tool 42 
for tracking the circulation of the virus among the population, including not only 43 
symptomatic patients, but also asymptomatic, presymptomatic and misdiagnosed 44 










carriers, which represent a high proportion of the infected population. In the specific 45 
case of Barcelona, wastewater surveillance anticipated several weeks not only the 46 
original COVID-19 pandemic wave, but also the onset of the second wave. In addition, 47 
SARS-CoV-2 occurrence in wastewater evidenced the efficacy of the adopted lockdown 48 
measures on the circulation of the virus.  49 
 Health authorities profited from WBE, to complement other inputs, and adopt rapid 50 
and adequate measures to mitigate the effects of the pandemic. As an example, sentinel 51 
surveillance of specific sewers helped to locate COVID-19 hot spots and to conduct 52 
massive RT-PCR tests among the population.  53 










Despite COVID-19 is a respiratory disease, the prolonged shedding of large amounts of 54 
coronavirus genomes in the feces (1, 2), that ultimately reach wastewater (3, 4), has 55 
been reported. Hence, SARS-CoV-2 surveillance in sewage is considered a sensitive 56 
tool to monitor the spread of the virus among the population (5-7). There is no 57 
epidemiological evidence that sewage could be a transmission route for SARS-CoV-2, 58 
through contamination of bathing areas or irrigation waters, because very few studies 59 
report culture of infectious virus from stool (8). As a matter of fact, Zang and coworkers 60 
reported that SARS-CoV-2 released into the intestinal lumen is inactivated by human 61 
colonic fluid, and hence infectious virus is seldom recovered from the stool specimens 62 
of COVID-19 patients (9). In addition, the specific infectivity of SARS-CoV-2 in 63 





genome copies (10, 11). Hence, infectious SARS-CoV-2 is unlikely to be present in 65 
wastewater.  66 
 To date, Spain ranks in the ninth place in absolute number of cases worldwide, and 67 
tops the list in Europe regarding the number of cases and deaths per 1 million 68 
inhabitants, with Barcelona the second most affected area in the country 69 
(https://www.worldometers.info/coronavirus/). The first case in Barcelona (actually the 70 
first in continental Spain) was reported on February 25, 2020. A complete lockdown 71 
was implemented in Spain in March 15, that gradually came to an end between May 25 72 
and June 21. The total number of reported cases in metropolitan Barcelona at the end of 73 
the lockdown in May 2020 was over 29,000 (https://salutweb.gencat.cat/ca/inici/nota-74 
premsa/index.html?id=385948#googtrans(ca|en).  75 
 Two large wastewater treatment plants, WWTP1 (capacity 525 million liters per day 76 
- MLD) and WWTP2 (capacity 420 MLD) cover around 2.7 M inhabitants, representing 77 










around 85% of the densely populated metropolitan area of Barcelona. The present 78 
extended study describes the evolution of the occurrence of SARS-CoV-2 RNA in these 79 
large WWTPs, before, during and after the lockdown, evidencing the validity of water-80 
based epidemiology (WBE) to i) anticipate COVID-19 outbreaks, ii) evaluate the 81 
impact of the control measures and iii) estimate the burden of infected patients, 82 
including presymptomatic, asymptomatic, symptomatic and undiagnosed cases. 83 
 84 
RESULTS AND DISCUSSION  85 
  Time-evolution of SARS-CoV-2 RNA in wastewater during the pandemic. The 86 
evolution of SARS-CoV-2 genome copies in sewage from the two main WWTPs in the 87 
metropolitan area of Barcelona is shown in Fig. 1. In WWTP1, maximum genome copy 88 
numbers of SARS-CoV-2 were detected in the initial sample collected on April 13. A 89 
progressive decrease was observed thereafter. This decrease was observed employing 90 
IP2 and IP4 targets, (Fig. 1, panel A) and confirmed with E and N1 (Fig. 1, panels B 91 
and C), and N2 (Fig. S1, Supplemental file) targets. On May 18, genomes disappeared, 92 
although residual levels could be again detected on May 25 employing the N1 target.  93 
 For WWTP2, samples from December 2019 to May 2020 were available, which 94 
opened the possibility to better analyze the dynamics of genome copy numbers in 95 
sewage. The analysis of archival samples revealed the increasing occurrence of SARS-96 
CoV-2 genomes in samples from January 15 to March 4 employing the IP2, IP4 and E 97 
targets (Fig. 1, panels D and E). Genome copy numbers peaked between March 4 and 98 
May 4 independently of the used target (Fig. 1, panel D-F). Of note, SARS-CoV-2 was 99 
detected in sewage 41 days (January 15) ahead of the declaration of the first COVID-19 100 
case (February 25), clearly evidencing the validity of wastewater surveillance to 101 










anticipate cases in the population. Again, as for WWTP1, genomes became undetectable 102 
on May 18 (Fig. 1, panels D and E) except when employing the N1 target, whose signal 103 
completely disappeared on May 25 (Fig. 1, panel F). The progressive decline in genome 104 
copy numbers in both WWTPs paralleled the diminution in the estimated cumulative 105 
number of shedders, based on the actual number of reported symptomatic cases, and 106 
figured for 7-day, 14-day and 21-day excretion periods before the sampling date (Fig. 107 
2). This genome copy decay evidences the effectivity of the lockdown measures on the 108 
spread of the infection.  109 
 On May 25, phase 1 of the gradual deconfinement was implemented (Fig. 1, Table 110 
S1). However, despite the apparent disappearance of SARS-CoV-2 RNA in the WWTPs 111 
around May 18-25, the analysis of grab samples, collected 8-9 AM on May 18 and 25, 112 
from four urban sewers revealed the occurrence of virus genomes (Fig. 3), indicating 113 
that the virus was still circulating in the population. A higher dilution factor applies in 114 
the WWTPs than in the sewers, which together with possible differences applying 115 
between grab and composite samples, as well as bowel habits (12), could explain why 116 
the WWTP samples came out to be negative for the virus, while genome copies could 117 
still be detected in the sewer samples. Sewer analysis may provide most relevant 118 
information for the specific localization of areas where COVID-19 cases reappear, 119 
enabling immediate response to prevent spread of the outbreak. Nevertheless, it 120 
represents a more laborious and costly approach than surveillance through WWTP 121 
monitoring.  122 
 Between June 2-8, SARS-CoV-2 genomes reappeared in both studied WWTPs and 123 
increased thereafter. All the RT-qPCR targets but the E target revealed this gradual raise 124 
(Fig. 1). Failure of the E target may be explained by the increasing circulation of viral 125 










variants with a recently described recurrent mutation affecting the probe-binding site 126 
(13). Throughout our study, five different RT-qPCR assays, targeting different genome 127 
regions were employed for SARS-CoV-2 detection in order to increase the robustness 128 
of our data. From our own experience in this and other unpublished studies on the 129 
occurrence of SARS-CoV-2 in wastewater, only 10% of the samples come out to be 130 
positive for the five RT-qPCR targets, indicating the need to employ more than one of 131 
these. In samples positive for all the five targets, the observed differences in Cq values, 132 
did not translate into major differences in genome copies in the corresponding standard 133 
curves (Fig. S1 and Fig. S2, supplemental file). However, since in our hands the N2 134 
target provided some inconsistent results in comparison with the rest of the employed 135 
targets, for the sake of clarity, data generated with the N2 target are only shown in Fig. 136 
S3 of the Supplemental file.  Current RT-PCR assays employed for SARS-CoV-2 in 137 
WBE studies are diverse and demand harmonization, as a step forward towards the 138 
development of standardized methodologies.   139 
 Phases 2 and 3 of the deconfinement were eventually applied on June 8 and 21, 140 
respectively (Fig. 1); phase 3 was delayed due to the SARS-CoV-2 levels detected in 141 
sewage. Nevertheless, in early July, a huge outbreak was declared (over 300 cases 142 
confirmed in 2 weeks and around 10,000 cases in 14 weeks 143 
(https://canalsalut.gencat.cat/ca/inici/nota-144 
premsa/index.html?id=387275#googtrans(ca|en) in a neighborhood whose sewers 145 
(Sewer3 and Sewer4, Fig. 3) drain into WWTP2, where genome copy numbers had 146 
started to increase around 3-4 weeks in advance (Fig. 1, panels D and F).  147 
 Estimation of the total number of active shedders from SARS-CoV-2 RNA 148 
levels in wastewater. WBE constitutes a valuable complementary tool for the 149 










surveillance of current infectious agents among the population (14, 15). In particular, 150 
WBE may contribute to a comprehensive management of the spread of SARS-CoV-2 151 
infection. Nevertheless, information is required to relate the detected genome copy 152 
numbers in wastewater with the numbers of infected individuals in the community, 153 
encompassing both symptomatic, presymptomatic, asymptomatic and undiagnosed 154 
shedders.  155 
 A simple and intuitive model was elaborated based on SARS-CoV-2 genome copy 156 
numbers per L of sewage, wastewater flow at the sampling point during the sampling 157 
period (Table S2), and genome copy numbers shed in the feces of infected individuals. 158 
Wölfel and colleagues (11) reported SARS-CoV-2 shedding in stool based on RT-qPCR 159 
employing the E target (16) (V.M. Corman, Charité Berlin, personal communication). 160 
Data generated with the E target were available from April 13 to May 11 and from 161 
March 31 to May 11, in samples from WWTP1 and WWTP2, respectively. The number 162 
of shedders, including symptomatic, presymptomatic, asymptomatic and undiagnosed 163 
cases, could be estimated following the model (Fig. 4). On April 13, this estimation was 164 
of 30,096 and 28,747 shedders, which accounted for a 2.0% and 2.4% prevalence, in 165 
WWTP1 and WWTP2, respectively. Yet, on March 31, the estimation was of 77,994 166 
shedders and 6.5% prevalence in WWTP2. The applied model provided a sound 167 
estimation of the number of shedders in our setting. However, the simplicity of the 168 
model enables further refinements related with the percent of shedders, that in our case 169 
was assumed to be 100%, and/or variations in virus load in feces of symptomatic, 170 
presymptomatic and asymptomatic shedders, when reliable data are available. An 171 
additional adjustment to the model is related with the threshold of genome copies in 172 
sewage to discern between periods of high and low stool excretion that in our case was 173 










established to be of 10
2.5 
gc/L. This value may vary depending on the WWTP type, the 174 
million liters per day capacity or on technical factors inherent to the SARS-CoV-2 175 
detection pipeline, i.e., virus concentration, RNA extraction and RT-qPCR efficiencies, 176 
and the reference material used in the standard curve, which all contribute to a certain 177 
degree of uncertainty. Additional sources of uncertainty are the limited number of 178 
assayed replicas, in our case genome copies were determined in duplicate, while only a 179 
single value of the daily wastewater flow was available. Nevertheless, for influenza, a 180 
well-characterized respiratory infection with similar transmissibility and for which 181 
natural and/or vaccine-induced immunity exists, a 2018 CDC study determined that the 182 
percentage of the U.S. population sickened each season by flu was about 8%, with a 183 
range of between 3% and 11%. When asymptomatic cases were also considered, the 184 
estimate raise from 5 to 20% (17), which is not far from our estimate of COVID-19 in 185 
metropolitan Barcelona. 186 
 Our data fall within the range of seroprevalence reported in the literature, taking into 187 
account the uncertainty of the seroprevalence assays, associated with the time of sample 188 
collection in the convalescence phase, the immunostatus and/or age of the patients and 189 
the employed determination kit. A study conducted in Spain based on the detection of 190 
antibodies directed to the S protein revealed an overall 5% seroprevalence (18), with 191 
substantial geographic variability, e.g., over 10% and 7% in the Madrid and Barcelona 192 
areas, respectively. Similarly, adjusted estimates of the persons seroreactive to SARS-193 
CoV-2 spike protein antibodies in the San Francisco and New York City areas were of 194 
1% and 7%, respectively (19).  195 
 Hart and Halden (20) reported through computational analysis that, in worst-case 196 
conditions, a 0.88% prevalence is required for successful detection of SARS-CoV-2 in 197 










sewage, while Ahmed and coworkers reduced this requirement to a prevalence of only 198 
0.025% (5). In the present study, the last positive RNA signal with the E target was 199 
observed on March 11 in both WWTP (Fig. 1). Applying our model, a proportion of 200 
around 0.12% and 0.09% of the total population (1,732 and 1,109 infected individuals) 201 
is required for positive detection in WWTP1 and WWTP2, respectively; Fig. 4). 202 
 Our SARS-CoV-2 early detection in sewage supports the idea that cases may have 203 
been present in the population before the first imported case was reported. COVID-19 204 
cases may have been misclassified as influenza diagnoses in primary care, boosting 205 
community transmission before public health measures were taken (21). Most COVID-206 
19 cases show mild influenza-like symptoms (22) and it has been suggested that some 207 
uncharacterized influenza cases may have masked some COVID-19 cases in the 2019-208 
2020 season (21).  209 
 Our data reveal the significant proportion of presymptomatic and asymptomatic 210 
carriers that nevertheless shed SARS-CoV-2 and contribute to the spread of the virus 211 
(23, 24). The enormous burden in morbidity and mortality of COVID-19 calls for 212 
sentinel surveillance of SARS-CoV-2 in wastewater to enable rapid mitigation measures 213 
in pandemic waves and to evaluate the usefulness of lockdown and deconfinement 214 
measures. Presently, surveillance networks comprising 56 WWTP in Catalonia 215 
(Catalonian Health Authority, Catalonian Water Agency and Catalonian Institute of 216 
Water Research, https://sarsaigua.icra.cat/), and 30 WWTP in Spain (VATar Project, 217 
Ministry of Health and Ministry of the Environment, 218 
https://www.miteco.gob.es/es/agua/temas/concesiones-y-autorizaciones/vertidos-de-219 
aguas-residuales/alerta-temprana-covid19/default.aspx) are implemented.  220 
  221 










Material and Methods 222 
 Wastewater samples. Composite raw sewage samples corresponding to 24 hours, 223 
were weekly collected from two large wastewater treatment plants (WWTP1 and 224 
WWTP2) in the metropolitan area of Barcelona from April 13, in the peak of the 225 
COVID-19 first wave, to July 7. In addition, for WWTP2, frozen archival samples 226 
monthly collected from January to March 2020 were also assayed. Furthermore, grab 227 
samples were collected from sewer maintenance holes on May 18 and 25, at 8-9 AM. 228 
Time of grab sample collection was selected according the bowel habits of the 229 
population (12) 230 
 Wastewater concentration. Eight hundred-milliliter samples of wastewater were 231 
concentrated through precipitation with 20% polyethylene-glycol 6000 and resuspended 232 
in 3 mL of PBS, pH 7.4 (25). In our hands, this procedure provides a mean recovery 233 
efficiency of 2.53% ± 0.17% of the attenuated porcine coronavirus PUR46-MAD strain 234 
of transmissible gastroenteritis virus (kindly provided by L. Enjuanes and I. Sola, 235 
National Center of Biotechnology, Cantoblanco, Madrid; 26). 236 
Nucleic acid extraction and virus quantification. Nucleic acid extraction was 237 
performed from 1mL of the concentrate and eluted in 50 µL using the NucliSENS® 238 
miniMAG® extraction system (bioMérieux).  239 
 Five one-step RT-qPCR assays (RNA UltraSense™ One-Step Quantitative RT-PCR 240 
System, Invitrogen, Life Technologies) were employed targeting the RNA-dependent 241 
RNA polymerase (RdRp) gene, IP2 and IP4 fragments, from Institute Pasteur, Paris 242 
(Institut Pasteur, Paris. Protocol: Real-time RT-PCR assays for the detection of SARS-243 
CoV-2. 2020 https://www.who.int/docs/default-source/coronaviruse/real-time-rt-pcr-244 











the envelope protein (E) gene, E fragment, from Charité, Berlin (16), and the 246 
nucleoprotein (N), N1 and N2 fragments, from CDC, Atlanta (Centers for Disease 247 
Control and Prevention A. CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-248 
PCR Diagnostic Panel. 2020 https://www.fda.gov/media/134922/download).  249 
 Standard curves were constructed using the Twist Synthetic SARS-CoV-2 RNA 250 
Control 2 (MN908947.3, Twist Bioscience). Figure S1 of the Supplemental file shows 251 
the average standard curves for each of the targets used.  252 
 Quality control and quality assurance to determine any potential contamination 253 
and/or inhibition, were ascertained using negative and positive controls, respectively. 254 
Positive controls consisted of the addition of two distilled water samples containing 255 
5x10
3
 copies of the Twist RNA, which were run in parallel in each RT-qPCR plate. 256 
Direct and 1/10 diluted replicas were assayed to ascertain assay inhibition. All 257 
quantitative assays were performed in duplicate, hence depicted genome copy numbers 258 
correspond to the mean of four values. Negative controls comprised five distilled water 259 
samples per run: two from the beginning of the assay, to control any potential 260 
contamination during the RNA extraction, and three in the RT-PCR, to control any 261 
potential contamination during nucleic acids amplification.  262 
 Estimation of SARS-CoV-2 shedders. The number of symptomatic SARS-CoV-2 263 
shedders was figured from the actual number of reported cases in the metropolitan 264 
Barcelona area (https://salutweb.gencat.cat/ca/inici/nota-265 
premsa/index.html?id=385948#googtrans(ca|en). Since SARS-CoV-2 excretion in stool 266 
has been reported to be variable and long-lasting (11, 27), we calculated the cumulative 267 
number of symptomatic shedders at each given date considering all cases reported on 268 










this date and in each of the previous seven (1-7) days, fourteen (1-14) days, and twenty-269 
one (1-21) days.  270 
 The total number of SARS-CoV-2 shedders (S), including asymptomatic, 271 
presymptomatic and undiagnosed virus carriers as well, was figured applying a model 272 
integrating the genome copy numbers per L of sewage (gc/L), the actual 24-h flow in L 273 
corresponding to each assayed composite sample (F), and the mean genome copy 274 
numbers per gram (gc/g) shed per infected patient. 275 
  S = gc/L ⁕ F  /  (gc/g stool ⁕ g stool), 276 
 Genome copy numbers in sewage were determined using the same E-targeted 277 
RT-qPCR assay developed at Charité, Berlin, employed for the quantification of the 278 
genomes present in stool (11, 16). The number of genomes excreted per patient, was 279 
figured by the product of the mean genome copy numbers excreted per gram of stool, 280 
and the average daily wet weight (w/w) of feces. This latter amount was figured to be 281 
380 g, based on an excretion of 30 g (w/w) per 5.5 Kg of body weight 282 
(https://www.emedicinehealth.com/) assuming an average weight of the Spanish 283 
population of 70 Kg (https://www.mscbs.gob.es/estadEstudios/sanidadDatos/), which 284 
falls within the previously reported range (28, 29). Genome copies shed by patients has 285 
been reported to range from less than 10
3
 gc/g, to over 10
7
 gc/g, depending on the time-286 
course of the infection, with higher titers during the first 10 days post symptom onset 287 
(11). Based on these data, we assumed a fecal excretion of 10
5.3
 gc/g (average for the 288 
first 10 days) or 10
4.9
 gc/g (average for the rest of the excretion period up to 21 days), 289 
depending on whether the number of genomes detected in sewage was higher or lower 290 
than 10
2.5
 gc/L (threshold established to discern between periods of high and low 291 
excretion), respectively.  292 
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FIGURE LEGENDS 416 
FIG 1 Evolution of SARS-CoV-2 genomes in two large Barcelona wastewater 417 
treatment plants (WWTP). Panels A and D: detection of the RNA-dependent RNA 418 
polymerase gene (IP2 and IP4 primers). Panels B and E: detection of the envelope 419 
protein gene (E primers). Panels C and F: detection of the nucleoprotein gene (N1 420 
primers). Absence of values at a given date is due to the unavailability of aliquots to 421 
assay. Dashed lines depict limits of detection. Red, orange and green arrows indicate 422 
Phase 1, Phase 2 and Phase 3 of the deconfinement, respectively. 423 
 424 
FIG 2 Cumulated SARS-CoV-2 shedders associated to WWTP1 and WWTP2, figured 425 
estimating fecal excretion periods of 7, 14 and 21 days, based on the actual number of 426 
reported symptomatic cases.  427 
 428 
FIG 3 SARS-CoV-2 genome copy levels in grab samples from four urban sewers, 429 
detected with targets IP2, IP4, E, N1 and N2. Sewer1 drains into WWTP1, while 430 
sewer2, sewer3 and sewer4 drain into WWTP2. 431 
 432 
FIG 4 Estimation of the total number of SARS-CoV-2 infected shedders, including 433 
symptomatic, presymptomatic, asymptomatic and undiagnosed cases. A model was 434 
developed based on the genome copies at the wastewater treatment plants detected 435 
during the first wave of the pandemic using the E target, the reported genome copies 436 
excreted in feces figured also employing the E target (11), and considering the actual 437 
daily wastewater flow.  438 
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